Search
Careers
Call Us Now: +1 (737) 787-4313
Menu
Controlled Substance Experts
Unified Services
API Process Development
Analytical Development
Formulation Development
Manufacturing Services
Regulatory Services
Commercial Services
Specialized Solutions
Discovery Booster
Clinical Expressway
Market Accelerator
Stability Solutions
Our Company
Company News
Company Events
Careers
Knowledge Center
Case Studies
Whitepapers
Our Company
Latest News &
Press Releases
Check out all of the most recent goings-on here at Benuvia.
Benuvia Operations Signs Commercial Supply Agreement with Leading U.S. Pharmaceutical Company for Dronabinol API
Read More
Benuvia Operations Signs Research & Development and Manufacturing Agreement with Trait Biosciences to Advance Next-Generation Cannabinoid-Based Products
Read More
Benuvia Operations Awarded NIH Contract for GMP Synthesis of Psilocybin and Other Bulk Drug Substances
Read More
Benuvia Operations Granted GMP Certification from Brazil National Health Surveillance Agency (ANVISA)
Read More
Benuvia Operations, LLC Enters into Licensing Agreement with Avernus Pharma for SYNDROS® CII (dronabinol) in the Gulf Cooperation Council Region
Read More
Benuvia Operations, LLC Enters into Licensing and Supply Agreements with Medra Brasil Medicamentos LTDA
Read More
Benuvia Operations, LLC and Department of Veterans Affairs Sign CRADA Agreement
Read More
Benuvia Appoints Terry Novak as New CEO
Read More
House passes Biosecure Act, sending Chinese biotech ban to Senate
Read More
Benuvia Operations, LLC Partners with Bright Green Corporation to Secure DEA-Approved Raw Materials for Pharmaceutical Innovation
Read More
Strategic Partnership to Advance Healthcare Solutions
Read More
Societal CDMO and Benuvia Sign Co-marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug Developers
Read More
1
2
Next »
